Streetbeat News

Analyst Ratings

APG

Barclays analyst Julian Mitchell maintains an Overweight rating on APi Gr (NYSE:APG) and raises the price target from $29 to $34.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:12 pm

ASAI

B of A Securities analyst Robert Ford has upgraded Sendas Distribuidora (NYSE:ASAI) from Neutral to Buy.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:11 pm

WISH

UBS analyst Kunal Madhukar maintains a Neutral rating on ContextLogic (NASDAQ:WISH) and lowers the price target from $7.8 to $6.5.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 07, 2023 | 1:10 pm

VXRT

Cantor Fitzgerald analyst Charles Duncan has maintained an Overweight rating on Vaxart (NASDAQ:VXRT) but lowered the price target from $6 to $4.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 07, 2023 | 1:08 pm

AMRX

Barclays analyst Balaji Prasad has maintained an Overweight rating on Amneal Pharmaceuticals (NYSE:AMRX) and raised the price target from $4 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:07 pm

FUBO

Stephens & Co. analyst Nicholas Zangler has reiterated an Equal-Weight rating on FuboTV (NYSE:FUBO) and maintained a $3 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:07 pm

GTN

Stephens & Co. analyst Nicholas Zangler has reiterated an Equal-Weight rating on Gray Television (NYSE:GTN) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:03 pm

FWRD

Stephens & Co. analyst Jack Atkins has reiterated an Overweight rating on Forward Air (NASDAQ:FWRD) and maintained a $130 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:02 pm

WELL

Wells Fargo analyst Todd Stender has maintained an Overweight rating on Welltower (NYSE:WELL) and raised the price target from $89 to $93.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:02 pm

EMR

Stephens & Co. analyst Tommy Moll has reiterated an Overweight rating on Emerson Electric (NYSE:EMR) and maintained a $120 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:01 pm